Ülke: Avustralya
Dil: İngilizce
Kaynak: Department of Health (Therapeutic Goods Administration)
Influenza virus haemagglutinin, Quantity: 30 microgram
Seqirus Pty Ltd
Influenza virus haemagglutinin
Injection, suspension
Excipient Ingredients: aluminium; dibasic sodium phosphate; calcium chloride dihydrate; potassium chloride; thiomersal; monobasic sodium phosphate; monobasic potassium phosphate; sodium chloride
Intramuscular
50 x 10 mL Vial
(S4) Prescription Only Medicine
Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with Australian Health Authorities' recommendations, taking into account the recommendation of the World Health Organisation.
Visual Identification: Creamy / white opaque liquid; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius
Registered
2008-06-12